Danaher Corporation $DHR Shares Bought by Kestra Advisory Services LLC

Kestra Advisory Services LLC grew its position in Danaher Corporation (NYSE:DHRFree Report) by 4.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 73,257 shares of the conglomerate’s stock after acquiring an additional 3,455 shares during the quarter. Kestra Advisory Services LLC’s holdings in Danaher were worth $13,890,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. JPL Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter worth $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher in the fourth quarter valued at $26,000. WFA of San Diego LLC purchased a new stake in shares of Danaher in the second quarter valued at about $26,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher in the fourth quarter valued at about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Price Performance

Shares of NYSE:DHR opened at $199.11 on Monday. The firm has a market capitalization of $140.92 billion, a price-to-earnings ratio of 38.51, a price-to-earnings-growth ratio of 2.54 and a beta of 0.79. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The business’s 50 day simple moving average is $180.59 and its 200-day simple moving average is $199.27. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period last year, the business posted $1.88 EPS. As a group, equities analysts forecast that Danaher Corporation will post 8.44 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is 30.95%.

Analysts Set New Price Targets

Several brokerages recently issued reports on DHR. DZ Bank assumed coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target on the stock. Jefferies Financial Group reaffirmed a “buy” rating and set a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. The Goldman Sachs Group dropped their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Royal Bank Of Canada began coverage on Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target for the company. Finally, Guggenheim decreased their price target on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $231.64.

View Our Latest Stock Report on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.